Literature DB >> 21138179

Complementary therapies, herbs, and other OTC agents: red clover (Trifolium pratense).

Barrie Cassileth1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21138179

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  4 in total

1.  Coagulation Disorder following Red Clover (Trifolium Pratense) Misuse: a Case Report.

Authors:  Sahar Karimpour-Reihan; Elnaz Firuzei; Malihe Khosravi; Mahsa Abbaszade
Journal:  Adv J Emerg Med       Date:  2018-01-12

Review 2.  Focusing on Formononetin: Recent Perspectives for its Neuroprotective Potentials.

Authors:  Jiao Tian; Xing-Qin Wang; Zhen Tian
Journal:  Front Pharmacol       Date:  2022-05-30       Impact factor: 5.988

Review 3.  Prospects for Trifolium Improvement Through Germplasm Characterisation and Pre-breeding in New Zealand and Beyond.

Authors:  Lucy M Egan; Rainer W Hofmann; Kioumars Ghamkhar; Valerio Hoyos-Villegas
Journal:  Front Plant Sci       Date:  2021-06-16       Impact factor: 5.753

Review 4.  Focus on Formononetin: Anticancer Potential and Molecular Targets.

Authors:  Samantha Kah Ling Ong; Muthu K Shanmugam; Lu Fan; Sarah E Fraser; Frank Arfuso; Kwang Seok Ahn; Gautam Sethi; Anupam Bishayee
Journal:  Cancers (Basel)       Date:  2019-05-01       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.